April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Fundus Fluorescein Angiography (FA) Complements OCT in Detecting Active Leakage in Patients With Exudative AMD
Author Affiliations & Notes
  • H. Tabandeh
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • N. A. Chaudhry
    New England Retina Associates, Hamden, Connecticut
  • V. Konjara
    New England Retina Associates, Hamden, Connecticut
  • T. Chu
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • D. Boyer
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • R. Novack
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • F. Rahhal
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • J. Hopkins
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • R. Roe
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • P. Dayani
    Retina Vitreous Assoc Med Group, Los Angeles, California
  • Footnotes
    Commercial Relationships  H. Tabandeh, None; N.A. Chaudhry, None; V. Konjara, None; T. Chu, None; D. Boyer, None; R. Novack, None; F. Rahhal, None; J. Hopkins, None; R. Roe, None; P. Dayani, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 529. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H. Tabandeh, N. A. Chaudhry, V. Konjara, T. Chu, D. Boyer, R. Novack, F. Rahhal, J. Hopkins, R. Roe, P. Dayani; Fundus Fluorescein Angiography (FA) Complements OCT in Detecting Active Leakage in Patients With Exudative AMD. Invest. Ophthalmol. Vis. Sci. 2010;51(13):529.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Introduction: : Background: Management of exudative AMD currently includes monthly intravitreal administration of anti-VEGF agents until the resolution of intra and subretinal fluid as observed on OCT. Once the OCT demonstrates absence of fluid, a drug-free interval is often considered. Although presence of intra and subretinal fluid on OCT likely represents accumulation of fluid due to active leakage from CNV complex, absence of fluid on OCT may not represent absence of active leakage. Physiological processes such as the "RPE pump" may successfully cope with subtle degrees of leakage, preventing accumulation of fluid that is detectable on OCT.

Purpose: : To study presence of leakage on FA in patients with exudative AMD who demonstrate resolution of intra and subretinal fluid on OCT following anti-VEGF therapy.

Methods: : Observational case series. Patients undergoing treatment for exudative AMD who demonstrated resolution of subretinal and retinal fluid on OCT (td or sd), underwent FA prior to considering a drug-free interval. Outcome measures included presence of leakage on FA and change in the size and composition of CNV complex.

Results: : Thirty one eyes were included in the study; 8 eyes (26%) demonstrated active leakage on FA while the OCT had not demonstrated evidence of intraretinal, sub-retinal, or sub-RPE fluid.

Conclusions: : In the setting of exudative AMD, subtle degrees of leakage from CNV may not result in accumulation of intra and subretinal fluid detectable by OCT. FA is valuable in detection of leakage when OCT fails to show fluid and a drug-free interval is being considered. High resolution OCT may detect subtle degrees of fluid in some of these case.

Keywords: age-related macular degeneration • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×